Jiangxi Sanxin Medtec Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 13.93%

Jiangxi Sanxin Medtec Co Ltd (300453) has an Asset Resilience Ratio of 13.93% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300453 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥321.71 Million
≈ $47.08 Million USD Cash + Short-term Investments

Total Assets

CN¥2.31 Billion
≈ $338.03 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Jiangxi Sanxin Medtec Co Ltd's Asset Resilience Ratio has changed over time. See 300453 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jiangxi Sanxin Medtec Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300453 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥321.71 Million 13.93%
Total Liquid Assets CN¥321.71 Million 13.93%

Asset Resilience Insights

  • Moderate Liquidity: Jiangxi Sanxin Medtec Co Ltd has 13.93% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Jiangxi Sanxin Medtec Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangxi Sanxin Medtec Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
Medical Instruments & Supplies 9.08%
Vizionfocus Inc.
TW:4771
Medical Instruments & Supplies 5.07%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 6.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Trajan Group Holdings Ltd
AU:TRJ
Medical Instruments & Supplies 0.23%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 43.09%

Annual Asset Resilience Ratio for Jiangxi Sanxin Medtec Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Jiangxi Sanxin Medtec Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 8.03% CN¥178.48 Million
≈ $26.12 Million
CN¥2.22 Billion
≈ $325.25 Million
+1.06pp
2023-12-31 6.97% CN¥141.57 Million
≈ $20.72 Million
CN¥2.03 Billion
≈ $297.17 Million
+4.69pp
2022-12-31 2.28% CN¥40.67 Million
≈ $5.95 Million
CN¥1.79 Billion
≈ $261.43 Million
+2.79pp
2021-12-31 -0.52% CN¥-7.25 Million
≈ $-1.06 Million
CN¥1.41 Billion
≈ $205.75 Million
-9.28pp
2020-12-31 8.76% CN¥109.09 Million
≈ $15.96 Million
CN¥1.24 Billion
≈ $182.15 Million
+7.02pp
2019-12-31 1.75% CN¥20.00 Million
≈ $2.93 Million
CN¥1.15 Billion
≈ $167.65 Million
+2.53pp
2018-12-31 -0.78% CN¥-6.46 Million
≈ $-944.88K
CN¥827.43 Million
≈ $121.08 Million
-9.58pp
2016-12-31 8.80% CN¥55.00 Million
≈ $8.05 Million
CN¥625.26 Million
≈ $91.50 Million
+7.35pp
2015-12-31 1.44% CN¥8.54 Million
≈ $1.25 Million
CN¥592.28 Million
≈ $86.67 Million
--
pp = percentage points

About Jiangxi Sanxin Medtec Co Ltd

SHE:300453 China Medical Instruments & Supplies
Market Cap
$770.09 Million
CN¥5.26 Billion CNY
Market Cap Rank
#10344 Global
#2994 in China
Share Price
CN¥10.08
Change (1 day)
-2.04%
52-Week Range
CN¥7.75 - CN¥11.10
All Time High
CN¥901119.83
About

Jiangxi Sanxin Medtec Co.,Ltd. engages in the research and development, manufacture, sale, and service of medical devices. The company offers infusion and cardiothoracic surgery products; and blood purification products, such as dialysate filter, dialysis indwelling needle, disposable biological protein glue dispenser, dialysis fluid filter, continuous blood purification pipeline and accessories,… Read more